MSD Nobivac DHPPI + Lepto Dog Vaccine

Live attenuated vaccine for immunization of Dogs against canine distemper virus(CDV), canine adenovirus type 1 (ICH), canine parvovirus (CPV) and canine parainfluenza virus (CPi).

Description:
A live attenuated vaccine for the immunization of dogs against canine distemper (CDV), canine contagious hepatitis caused by canine adenovirus type 1 (ICH), canine parvovirus disease (CPV) and respiratory disease caused by canine parainfluenza (CPi) and canine adenovirus type 2 (CAV2)

Composition:
Each dose contains live attenuated strains of:
Canine Parvo virus (strain C 154) ≥10⁷ TCID₅₀
Canine Distemper virus (strain Onderstepoort) ≥ 10⁴ TCID₅₀
Canine Adeno virus type 2 (strain Manhattan LPV3) ≥ 10⁴ TCID₅₀
Canine Para-influenza virus (strain Cornell) ≥10^5.5 TCID₅₀

Nobivac Lepto

Description:
A bivalent, inactivated vaccine for the immunization of dogs against leptospirosis caused by Leptospira canicola and Leptospira icterohaemorrhagiae.

Composition
Each dose of inactivated vaccine contains
Leptospira interrogans serotype Canicola strain Ca-12-000 at least 957 units/ml
Icterohaemorrhagiae strain 820k at least 625 units/ml

Indications
Active immunisation against Leptospirosis caused by Leptospira icterohaemorrhagiae and Leptospira canicola of Leptospira interrogans. Animals are protected against clinical disease, and against becoming renal carriers after challenge.

Dosage and Administration
Inject 1ml of Nobivac Lepto subcutaneously. Nobivac Lepto can also be used to reconstitute Intervet’s freeze dried vaccines, Nobivac Puppy DP and Nobivac DHPPi.

Vaccination Programme
Nobivac Lepto is indicated for a basic vaccination schedule with a first vaccination at the age of 8 – 9 weeks of age, followed by a booster at 12 weeks of age, and for annual revaccination.
Vaccination with Nobivac Lepto, however is part of a comprehensive vaccination programme. Several alternatives exist (Refer Product Leaflet for more information).